Lastly, prior studies demonstrated that IGF2 activates PI3K/AKT and MAPK pathways as downstream of IGF2 in osteoarthritis and cancer to promote proliferation, survival, and disease progression 61-63. The gene discussed is AKT1; the disease is osteoarthritis.